{
 "ticker": "BMED",
 "name": "iShares Health Innovation Active ETF",
 "issuer": "iShares",
 "desk": "themes",
 "url": "https://etfiq.com/funds/bmed",
 "html": "https://etfiq.com/funds/bmed",
 "markdown": "https://etfiq.com/funds/bmed.md",
 "as_of": "2026-09-11",
 "verdict": "BMED holds 50 stocks, and 39% of its weight is outside the S&P 500.",
 "key_facts": [
  {
   "key": "already_in_the_s_p_500",
   "label": "Already in the S&P 500",
   "value": "60.8%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "BMED, already in the S&P 500: 60.8%, as of Sep 11, 2026."
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "95.7%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "BMED, active share vs the S&P 500: 95.7%, as of Sep 11, 2026."
  },
  {
   "key": "top_ten_holdings",
   "label": "Top ten holdings",
   "value": "42.6%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "BMED, top ten holdings: 42.6%, as of Sep 11, 2026."
  },
  {
   "key": "total_return_1_year",
   "label": "Total return, 1 year",
   "value": "+23.6%",
   "source": null,
   "as_of": "2026-09-11",
   "sentence": "BMED, total return, 1 year: +23.6%, as of Sep 11, 2026."
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$13m",
   "source": "the issuer own daily fund list, as of Sep 11, 2026",
   "as_of": "2026-09-11",
   "sentence": "BMED, net assets: $13m (the issuer own daily fund list, as of Sep 11, 2026)."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.55%",
   "source": "485BPOS XBRL, Nov 21, 2025",
   "as_of": "2026-09-11",
   "sentence": "BMED, expense ratio: 0.55% (485BPOS XBRL, Nov 21, 2025)."
  }
 ],
 "fields": [
  {
   "key": "theme",
   "label": "Theme",
   "value": "Healthcare innovation and GLP-1",
   "source": "ETFIQ, editorial"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "Oct 1, 2020",
   "source": null
  },
  {
   "key": "already_in_the_s_p_500_by_weight",
   "label": "Already in the S&P 500, by weight",
   "value": "60.8%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_s_p_500",
   "label": "Active share vs the S&P 500",
   "value": "95.7%",
   "source": "ETFIQ"
  },
  {
   "key": "already_in_the_nasdaq_100_by_weight",
   "label": "Already in the Nasdaq-100, by weight",
   "value": "13.4%",
   "source": "ETFIQ"
  },
  {
   "key": "active_share_vs_the_nasdaq_100",
   "label": "Active share vs the Nasdaq-100",
   "value": "97.8%",
   "source": "ETFIQ"
  },
  {
   "key": "top_ten_holdings_weight",
   "label": "Top ten holdings weight",
   "value": "42.6%",
   "source": null
  },
  {
   "key": "holdings",
   "label": "Holdings",
   "value": "50",
   "source": null
  },
  {
   "key": "holdings_as_of",
   "label": "Holdings as of",
   "value": "Sep 10, 2026",
   "source": "the issuer\u2019s daily file"
  },
  {
   "key": "top_holdings",
   "label": "Top holdings",
   "value": "GILEAD SCIENCES 5.1%, MERCK & CO INC 5.0%, ABBVIE 4.7%, JOHNSON & JOHNSON 4.4%, THERMO FISHER SCIENTIFIC INC 4.2%, CHARLES RIVER LABORATORIES INTERNA 4.1%, EDWARDS LIFESCIENCES 3.9%, MODERNA 3.9%, IQVIA HOLDINGS 3.8%, BIOGEN 3.5%",
   "source": null
  },
  {
   "key": "net_assets",
   "label": "Net assets",
   "value": "$13m",
   "source": "the issuer own daily fund list, as of Sep 11, 2026"
  },
  {
   "key": "below_its_all_time_high",
   "label": "Below its all-time high",
   "value": "\u22125.3%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.55%",
   "source": "485BPOS XBRL, Nov 21, 2025"
  },
  {
   "key": "fee_for_the_part_that_differs_from_the_s_p_500_active_expense_ratio",
   "label": "Fee for the part that differs from the S&P 500, active expense ratio",
   "value": "0.57%",
   "source": "ETFIQ"
  },
  {
   "key": "closest_funds_by_holdings_overlap",
   "label": "Closest funds by holdings overlap",
   "value": "BBH 35%, IBBQ 34%, PBPH 32%, GDOC 31%, PBE 27%",
   "source": null
  }
 ],
 "periods": [
  {
   "window": "3 months",
   "Total return": "+15.8%",
   "S&P 500": "+3.3%",
   "Gap to S&P 500": "+12.5 pts",
   "Gap to Nasdaq-100": "+16.6 pts"
  },
  {
   "window": "6 months",
   "Total return": "+15.5%",
   "S&P 500": "+16.0%",
   "Gap to S&P 500": "\u22120.6 pts",
   "Gap to Nasdaq-100": "\u22125.2 pts"
  },
  {
   "window": "1 year",
   "Total return": "+23.6%",
   "S&P 500": "+17.5%",
   "Gap to S&P 500": "+6.1 pts",
   "Gap to Nasdaq-100": "+0.6 pts"
  },
  {
   "window": "3 years",
   "Total return": "+39.7%",
   "S&P 500": "+77.9%",
   "Gap to S&P 500": "\u221238.1 pts",
   "Gap to Nasdaq-100": "\u221255.4 pts"
  },
  {
   "window": "Since launch",
   "Total return": "+29.6%",
   "S&P 500": "+145.3%",
   "Gap to S&P 500": "\u2212115.7 pts",
   "Gap to Nasdaq-100": "\u2212132.5 pts"
  }
 ],
 "questions": [
  {
   "q": "How much of BMED is in S&P 500 companies?",
   "a": "By its holdings published by its issuer for Sep 10, 2026, 61% of BMED by weight is stocks the S&P 500 already holds. Its active share against the index is 96%, so that share is the part doing something different."
  },
  {
   "q": "What does BMED hold?",
   "a": "50 positions as published by its issuer for Sep 10, 2026, with the top ten at 43% of the fund. The largest are GILEAD SCIENCES at 5.1%, MERCK & CO INC at 5.0%, ABBVIE at 4.7%."
  },
  {
   "q": "Has BMED beaten the S&P 500?",
   "a": "Over the year to Sep 11, 2026 BMED returned +23.6% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 6.1 points."
  },
  {
   "q": "What does BMED cost?",
   "a": "The prospectus expense ratio is 0.55% a year. Because 96% of the fund differs from the S&P 500, the fee on that differing part works out at 0.57%."
  }
 ],
 "generated": "2026-09-13",
 "license": "Free to use with attribution. ETFIQ (etfiq.com)."
}